Our results are in line with a very recent report showing that BM mesenchymal cells from MM patients with active disease express higher levels of gene transcription and protein expression of the genes involved in the PI3K/AKT/mTOR pathway. This evidence concerns the gene MTOR and Miyoshi myopathy.